CRA halted for news at close on Friday. I don't know if anyone is lurking out there...but these gene companies are important investments for this decade. They're expensive,,but it's still early...and they're going to get more expensive. I imagine CRA is due for a split and HGSI is splitting. MLNM is probably not far from it, either.
INCY has gone absolutely beserk in the last few weeks.
Any pullback in the market...I'd add these puppies.
Venter is the chief at CRA and he's a headline seeker. I suspect he will keep releasing news that will keep CRA in the limelight. He likes the notoriety.
Friday January 7, 7:11 pm Eastern Time
Company Press Release
SOURCE: Celera Genomics Group
Celera Genomics News Briefing to Provide Update on Human Genome Sequencing
WHO: J. Craig Venter, Ph.D., Celera, President and Chief Scientific Officer
WHAT: Celera Genomics to hold news briefing to announce and explain the achievement of a key
milestone in sequencing of the human genome.
WHEN: MONDAY, JANUARY 10, 2000
11:00 AM EST
WHERE: Join us at Celera Genomics, 45 West Gude Drive, Rockville, MD
(Off Route 355)
Or, join us via telebriefing by dialing # 1-800-810-0924, and ask to be connected with the Celera
conference call. An interactive Q&A session will follow the announcement.
Or, access the news briefing via listen-only webcast at l:
webevents.broadcast.com Please note, you may only participate in
the interactive Q&A session following the announcement by dialing in to the teleconference at
1-800-810-0924.
Company Background
Celera's mission is to become the definitive source of genomic and related agricultural and medical
information. Users of Celera's information, available on a subscription basis to academic and
commercial institutions, will have access to tools for viewing, browsing and analyzing data in an
integrated way that will assist scientists in accelerating their understanding of the human genetic
code.
PE Corporation currently comprises two operating groups. Celera Genomics Group,
headquartered in Rockville, MD, intends to become the definitive source of genomic and related
medical information. PE Biosystems Group, headquarted in Foster City, CA and with sales of
$1.2 billion during fiscal 1999, develops and markets instrument-based systems, reagents,
software, and contract related services to the life science industry and research community.
CONTACT: Luvon Roberson, 212-453-2144, or Elizabeth McHenry, 212-453-2460, both for
Celera Genomics Group.
SOURCE: Celera Genomics Group |
